| 翻訳と辞書 |
| Journal of the American Academy of Child and Adolescent Psychiatry ： ウィキペディア英語版 |
Journal of the American Academy of Child and Adolescent Psychiatry
The ''Journal of the American Academy of Child and Adolescent Psychiatry'' is a peer-reviewed medical journal covering pediatric psychiatry. It is published by Elsevier and is the official journal of the American Academy of Child and Adolescent Psychiatry. The editors-in-chief are Andrés Martin and James J. Hudziak.
According to the ''Journal Citation Reports'', its 2014 impact factor is 7.26, ranking it first among 119 journals in the category "Pediatrics". It is abstracted and indexed in MEDLINE/PubMed, and Science Citation Index.
==Call for retraction==
The group Healthy Skepticism has accused the journal of having published an article, in 2001, that misrepresented the results of an industry-sponsored clinical trial, study 329. The study examined the use of paroxetine by teenagers.〔Martin Keller, et al, ("Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial" ), ''Journal of the American Academy of Child and Adolescent Psychiatry'', 40(7), July 2001, pp. 762–772. PMID 11437014〕 The trial was sponsored by, and ghostwritten on behalf of, SmithKline Beecham (now GlaxoSmithKline), and is widely regarded as having downplayed the trial's negative results. ''JAACAP'' editors have declined to retract the article, arguing that the negative results are available in the article, and that therefore there are no grounds for retraction. This claim is disputed on the basis that primary and secondary outcomes for efficacy were manipulated and safety results were obscured or omitted. Critics therefore argue that the Journal's editors have failed to uphold the scientific standards of clinical research by failing to retract a fraudulent article. 〔Isabel Heck, ("Controversial Paxil paper still under fire 13 years later" ), ''The Brown Daily Herald'', 2 April 2014.〕〔Melanie Newman, ("The Rules of Retraction" ), ''BMJ'', 341(7785), 11 December 2010, pp. 1246–1248. PMID 21138994〕〔Jon N. Jureidini, Leemon B. McHenry, Peter R. Mansfield, ("Clinical trials and drug promotion: Selective reporting of study 329" ), ''International Journal of Risk & Safety in Medicine'', 20, 2008, pp. 73–81. 〕〔Leemon B. McHenry, Jon N. Jureidini, "Industry-sponsored ghostwriting in clinical trial reporting: a case study," ''Accountability in Research: Policies and Quality Assurance'', 15(3), July–September 2008, pp. 152–167. PMID 18792536〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Journal of the American Academy of Child and Adolescent Psychiatry」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|